Intrust Bank Na Gilead Sciences, Inc. Transaction History

Intrust Bank Na

$995 Million
Q3 2024

A detailed history of Intrust Bank Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 24,329 shares of GILD stock, worth $2.29 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

24,329

Previous 22,705 7.15%

Holding current value

$2.29 Million

Previous $1.56 Million 30.96%

% of portfolio

0.2%

Previous 0.17%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $108,142 - $136,399	1,624 Added 7.15%	24,329 $2.04 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $225,761 - $260,545	-3,575 Reduced 13.6%	22,705 $1.56 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $58,337 - $71,141	815 Added 3.2%	26,280 $1.93 Million
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $156,284 - $177,230	2,133 Added 9.14%	25,465 $2.06 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $94,347 - $102,934	-1,276 Reduced 5.19%	23,332 $1.75 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $169,654 - $193,514	-2,232 Reduced 8.32%	24,608 $1.9 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $121,995 - $138,990	-1,578 Reduced 5.55%	26,840 $2.23 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $72,228 - $103,695	-1,159 Reduced 3.92%	28,418 $2.44 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $170,105 - $194,304	2,857 Added 10.69%	29,577 $1.83 Million
Q2 2022 Aug 16, 2022	BUY	$57.72 - $65.01 $218,123 - $245,672	3,779 Added 16.47%	26,720 $1.65 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $44,366 - $55,596	766 Added 3.45%	22,941 $1.36 Million
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $15,441 - $17,526	238 Added 1.08%	22,175 $1.61 Million
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $154,807 - $167,019	2,287 Added 11.64%	21,937 $1.53 Million
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $140,522 - $153,540	2,214 Added 12.7%	19,650 $1.35 Million
Q1 2021 Jun 02, 2021	BUY	$60.0 - $68.46 $4,200 - $4,792	70 Added 0.4%	17,436 $1.13 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $261,213 - $297,640	-4,611 Reduced 20.98%	17,366 $1.01 Million
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $235,793 - $296,469	-3,797 Reduced 14.73%	21,977 $1.39 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $246,317 - $286,020	-3,405 Reduced 11.67%	25,774 $1.98 Million
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $591,602 - $757,758	9,446 Added 47.87%	29,179 $2.18 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $81,954 - $90,147	-1,330 Reduced 6.31%	19,733 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $86,513 - $95,496	1,384 Added 7.03%	21,063 $1.34 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $233,868 - $262,256	3,780 Added 23.78%	19,679 $1.33 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $3,063 - $3,432	49 Added 0.31%	15,899 $1.03 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $247,124 - $322,478	-4,082 Reduced 20.48%	15,850 $992,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $28,155 - $31,173	-395 Reduced 1.94%	19,932 $1.54 Million
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $119,963 - $139,932	1,849 Added 10.01%	20,327 $1.44 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $63,735 - $77,700	875 Added 4.97%	18,478 $1.39 Million
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $15,724 - $18,457	221 Added 1.27%	17,603 $1.26 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $1.25 Million - $1.49 Million	17,382	17,382 $1.41 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account